Glazer Capital LLC’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-390,098
Closed -$4.63M 258
2025
Q1
$4.63M Sell
390,098
-5,284
-1% -$62.1K 0.21% 70
2024
Q4
$4.61M Sell
395,382
-2,366
-0.6% -$27.4K 0.31% 49
2024
Q3
$4.56M Sell
397,748
-5,043
-1% -$57.4K 0.27% 48
2024
Q2
$4.54M Sell
402,791
-7,309
-2% -$82K 0.35% 56
2024
Q1
$4.56M Sell
410,100
-6,782
-2% -$74.9K 0.47% 50
2023
Q4
$4.57M Buy
416,882
+76,475
+22% +$832K 0.47% 53
2023
Q3
$3.68M Sell
340,407
-13,406
-4% -$144K 0.24% 72
2023
Q2
$3.77M Buy
353,813
+262,420
+287% +$2.78M 0.25% 82
2023
Q1
$959K Hold
91,393
0.05% 200
2022
Q4
$937K Buy
+91,393
New +$927K 0.02% 283

Other funds holding RENE

Glazer Capital LLC's RENE Position: Q2 2025 in Review

Glazer Capital LLC sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 390,098 shares — an estimated $4.63M sold.

Glazer Capital LLC first reported a position in RENE in Q4 2022 and held it in 10 quarters. The position peaked at $4.63M in Q1 2025. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Glazer Capital LLC reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 390,098 Cartesian Growth Corp II shares in Q2 2025, an estimated $4.63M.
  • Glazer Capital LLC first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 10 quarters.
  • Glazer Capital LLC's Cartesian Growth Corp II position peaked at $4.63M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.